港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

科倫博泰生物-B

425.800

+4.8001.14%

成交量：55.88萬

成交額：2.41億

市值：992.91億

市盈率：-353.78

高：441.600

開：420.800

低：418.800

收：421.000

52周最高：581.000

52周最低：228.200

股本：2.33億

香港流通股本：1.63億

量比：0.95

換手率：0.34%

股息：- -

股息率：- -

每股收益(LYR):-1.204

淨資產收益率：-9.34%

總資產收益率：-4.26%

市淨率：18.02

市盈率(LYR):-353.78

市銷率: 42.61

資料載入中...

總覽公司新聞資訊公告

《大行》招銀國際升科倫博泰(06990.HK)目標價至507.11元評級「買入」

阿斯达克财经

【券商聚焦】招銀國際維持科倫博泰(06990)「買入」評級指2025年為向商業化轉型的關鍵之年

《大行》里昂降科倫博泰生物(06990.HK)目標價至500.7元評級「跑贏大市」

阿斯达克财经

高盛重申「買入」科倫博泰生物-B(06990)：蘆康沙妥珠單抗OS數據表現突出公司增長潛力持續釋放

科倫博泰生物-B(06990)： SKB103新藥臨床試驗申請獲國家藥品監督管理局批准

科倫博泰生物-B SKB103新藥臨床試驗申請獲中國國家藥監局批准用於晚期實體瘤

港股異動 | TSLP抗體療法I期臨床研究結果發表科倫博泰生物-B(06990)升逾7% 和鉑醫藥-B(02142)升逾4%

科倫博泰生物-B公布2025年度業績：多款產品成功上市，梯隊化管線蓄勢待發

異動解讀 | 瑞銀重申「買入」評級，科倫博泰生物-B盤中大漲5.03%

《大行》高盛降科倫博泰(06990.HK)目標價至526.49元下調每股盈測

阿斯达克财经

《大行》瑞銀降科倫博泰(06990.HK)目標價至578元降盈測重申「買入」

阿斯达克财经

ADC一哥，扣動新一輪增長扳機

《業績》科倫博泰生物(06990.HK)全年虧損擴至3.82億人幣

阿斯达克财经

科倫博泰生物－Ｂ(06990)股價下跌5.044%，現價港幣$410.4

阿斯达克财经

【券商聚焦】中國銀河：「十五五」首次將生物醫藥列為國家新興支柱產業，持續發力研發創新

科倫博泰生物-B(06990)：核心產品蘆康沙妥珠單抗(sac-TMT)於2025年歐洲肺癌大會上公布的研究成果

科倫博泰生物－Ｂ(06990)股價上升5.066%，現價港幣$414.8

阿斯达克财经

每日沽空追蹤 | 科倫博泰生物-B 03月11日沽空量成交5.25萬股，沽空比例為14.19%

科倫博泰生物-B(06990)與科倫嘉訊訂立2026年輔助性市場管理服務框架協議

港股異動 | 創新藥概念股普漲，康方生物、科倫博泰生物升逾9%

老虎资讯综合

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06990/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科倫博泰生物-B","latestPrice":425.8,"timestamp":1774426112006,"preClose":421,"halted":0,"volume":558821,"delay":0,"changeRate":0.011401425178147295,"floatShares":162769979,"shares":233185969,"eps":-1.203559,"marketStatus":"未開盤","change":4.8,"latestTime":"03-25 16:08:32","open":420.8,"high":441.6,"low":418.8,"amount":240628879,"amplitude":0.054157,"askPrice":426,"askSize":500,"bidPrice":425.8,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.814,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774488600000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":421,"openAndCloseTimeList":[[1774402200000,1774411200000],[1774414800000,1774425600000]],"volumeRatio":0.9490075362675878,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-4.26%","roe":"-9.34%","lyrEps":-1.203559,"volumeRatio":0.9490075362675878,"shares":233185969,"dividePrice":0,"high":441.6,"amplitude":0.054157,"preClose":421,"low":418.8,"week52Low":228.2,"pbRate":"18.02","psRate":"42.61","week52High":581,"institutionHeld":0,"latestPrice":425.8,"eps":-1.203559,"divideRate":0,"volume":558821,"delay":0,"ttmEps":-1.814,"open":420.8,"prevYearClose":392.2,"prevWeekClose":417.6,"prevMonthClose":387.4,"prevQuarterClose":392.2,"fiveDayClose":431.4,"twentyDayClose":400,"sixtyDayClose":418.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5789,"hold":0.0526,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5789,"analysts":19,"updateTime":1772726400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-03-24","current":-234.729879,"percent":0.152924,"low":-351.800852,"twenty":-169.755116,"median":-124.510593,"eighty":-50.803766,"high":-21.029201,"avg":-126.360079,"sd":76.861179,"marketCap":98171306000},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-24","current":-226.321032,"twenty":-169.755116,"median":-124.510593,"eighty":-50.803766,"marketCap":98171306000}],"updateTime":1774427223514},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622602541","title":"《大行》招銀國際升科倫博泰(06990.HK)目標價至507.11元  評級「買入」","url":"https://stock-news.laohu8.com/highlight/detail?id=2622602541","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622602541?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 16:29","pubTimestamp":1774427340,"startTime":"0","endTime":"0","summary":"招银国际发表研究报告指，科伦博泰(06990.HK) 去年总收入达20.6亿元人民币，按年升6.5%，其中产品销售收入5.43亿元人民币。三大核心资产包括Sac-TMT、A167 和 A140均成功纳入国家医保目录，为2026年的销量增长奠定了坚实基础。尽管因商业化扩张和后期临床推进导致净亏损扩大至3.82亿元人民币，但公司资金充裕，截至2025年底拥有46亿元人民币现金及金融资产。该行将公司目标价由498.55港元上调至507.11港元，维持其评级为“买入”。(ca/u)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-25 12:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1512359/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1512359/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2622044491","title":"【券商聚焦】招銀國際維持科倫博泰(06990)「買入」評級 指2025年為向商業化轉型的關鍵之年","url":"https://stock-news.laohu8.com/highlight/detail?id=2622044491","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622044491?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 13:48","pubTimestamp":1774417714,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，2025年是科伦博泰 向商业化转型的关键之年，公司已从临床阶段的生物科技公司成功转型为拥有4款获批产品的生物制药企业。三大核心资产成功纳入国家医保目录，为2026年的销量增长奠定了坚实基础。该机构预计默沙东有望在2026年提交用于二线及以上子宫内膜癌的上市申请，或有望在2026年底或2027年初获批。维持“买入”评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977202","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2622904940","title":"《大行》里昂降科倫博泰生物(06990.HK)目標價至500.7元 評級「跑贏大市」","url":"https://stock-news.laohu8.com/highlight/detail?id=2622904940","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622904940?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 12:15","pubTimestamp":1774412100,"startTime":"0","endTime":"0","summary":"里昂发表研究报告指，科伦博泰生物去年收入按年升6.5%至20.58亿元人民币，净亏损按年扩大43.2%至3.82亿元人民币，均胜于预期，主要受合作收入强于预期所带动。该行指，2025年下半年产品销售按半年增长。该行将科伦博泰生物今明两年的销售预测分别下调15.7%及11.9%，纯利预测下调85.9%及51.5%，目标价由548.6元下调至500.7元，维持“跑赢大市”评级。沽空资料截至 2026-03-24 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1512249/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1512249/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2621065283","title":"高盛重申「買入」科倫博泰生物-B(06990)：蘆康沙妥珠單抗OS數據表現突出 公司增長潛力持續釋放","url":"https://stock-news.laohu8.com/highlight/detail?id=2621065283","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621065283?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 18:30","pubTimestamp":1774348218,"startTime":"0","endTime":"0","summary":"高盛认为，其核心产品芦康沙妥珠单抗已成为公司增长的核心驱动力。2026年，随着产品已纳入国家医保目录，公司预计芦康沙妥珠单抗的销售将实现大幅增长，并有望在已获批适应症中成为医生首选，这部分预计将贡献超过80%的收入。此前，公司已宣布芦康沙妥珠单抗联合帕博利珠单抗一线治疗PD-L1阳性非小细胞肺癌的III期研究已达到主要终点，进一步验证这一ADC+IO联用组合的临床价值。RDC的全球热度正在升温，科伦博泰已经提前完成卡位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"高盛重申“买入”科伦博泰生物-B(06990)：芦康沙妥珠单抗OS数据表现突出 公司增长潜力持续释放","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443382.USD","LU2237443622.USD","IE00BSNM7G36.USD","LU1894683348.USD","LU1868837136.USD","LU0106831901.USD","BK4585","LU0061475181.USD","IE00BFXG1179.USD","IE00B19Z3581.USD","LU0196878994.USD","LU0251131958.USD","LU0345770308.USD","LU1668664300.SGD","LU0096364046.USD","LU2471134796.USD","LU2471134879.HKD","BK4552","IE0034235188.USD","LU2750360641.GBP","BK4533","BK4588","GSX","BK4550","06990","IE0004091025.USD","LU2237443465.HKD","LU2471134523.USD","LU0345770993.USD","LU2237438978.USD","LU2237443895.HKD","IE0004086264.USD","LU2237443978.SGD","BK4516","LU0251142724.SGD","LU1868836591.USD","IE0002270589.USD","LU2237443549.SGD","LU2750360997.AUD","LU1868836757.USD","LU1868836914.USD","LU1894683264.USD","LU2265009873.SGD","BK1161","BK4127","LU0742534661.SGD","IE00B19Z3B42.SGD","LU1791807156.HKD","LU1804176565.USD","LU0048573561.USD"],"gpt_icon":0},{"id":"2621057905","title":"科倫博泰生物-B(06990)： SKB103新藥臨床試驗申請獲國家藥品監督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2621057905","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621057905?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 16:48","pubTimestamp":1774342081,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，本公司自主研发的新型靶向肿瘤相关抗原及免疫肿瘤学抗原的双特异性抗体偶联药物  SKB103的新药临床试验申请已获国家药品监督管理局 药品审评中心批准，用于治疗晚期实体瘤。这是本公司首个进入临床阶段的TAA-PD-L1 bsADC，也是继SKB571之后第二款进入临床阶段的用于肿瘤治疗的bsADC。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"科伦博泰生物-B(06990)： SKB103新药临床试验申请获国家药品监督管理局批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1125512630","title":"科倫博泰生物-B SKB103新藥臨床試驗申請獲中國國家藥監局批准用於晚期實體瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1125512630","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125512630?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 16:47","pubTimestamp":1774342031,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其创新药物SKB103的新药临床试验申请已正式获得中国国家药品监督管理局批准，将针对晚期实体瘤开展临床研究。此次获批标志着该药物在肿瘤治疗领域迈出关键一步，为后续研发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2621059310","title":"港股異動 | TSLP抗體療法I期臨床研究結果發表 科倫博泰生物-B(06990)升逾7% 和鉑醫藥-B(02142)升逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621059310","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621059310?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 15:02","pubTimestamp":1774335720,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科伦博泰生物-B、和铂医药-B午后涨幅扩大。截至发稿，科伦博泰生物涨7.34%，报426.8港元；和铂医药涨4.65%，报11.7港元。消息面上，3月23日，和铂医药宣布，HBM9378首次人体1期临床试验结果已在线发表于同行评议期刊Drug Design, Development and Therapy。公开资料显示，HBM9378由和铂医药与科伦博泰联合开发，双方共同享有其全球权益。2025年1月，和铂医药及科伦博泰与Windward Bio签订战略合作，授予后者在全球范围内对该抗体进行研究、开发、生产和商业化的独家权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","BK1161","BK4588","BK1583","02142","BK1574","LU0196878994.USD","VXUS","BK4585"],"gpt_icon":0},{"id":"1188074054","title":"科倫博泰生物-B公布2025年度業績：多款產品成功上市，梯隊化管線蓄勢待發","url":"https://stock-news.laohu8.com/highlight/detail?id=1188074054","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188074054?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 10:32","pubTimestamp":1774319536,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B（股票代码：06990）正式披露了其2025年度的财务与业务进展。报告期内，公司成功实现了多款创新产品的商业化上市，标志着其研发成果进入收获期。与此同时，公司构建的梯队化产品管线布局完善，后续增长动力充足，展现出强劲的发展潜力，为未来的持续飞跃奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1172232004","title":"異動解讀 | 瑞銀重申「買入」評級，科倫博泰生物-B盤中大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1172232004","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172232004?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 10:26","pubTimestamp":1774319198,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B今日盘中大涨5.03%，引起了市场的广泛关注。消息面上，瑞银发表研究报告指出，科伦博泰生物-B去年下半年收入同比增长101%，符合预期；净亏损好于预期；毛利率提升至74%。尽管瑞银下调了其目标价及部分盈利预测，但报告重申了“买入”评级，这增强了市场对公司基本面的信心。报告显示，公司毛利率的提升主要受产品销售占比提高带动。瑞银预计，随着今年更多第三期临床数据释出，公司可能获得潜在的里程碑付款，从而带来授权收入。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06990"],"gpt_icon":0},{"id":"2621034668","title":"《大行》高盛降科倫博泰(06990.HK)目標價至526.49元 下調每股盈測","url":"https://stock-news.laohu8.com/highlight/detail?id=2621034668","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621034668?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 10:24","pubTimestamp":1774319040,"startTime":"0","endTime":"0","summary":"管理层预期今年sac-TMT销售将倍增，目标成为医保目录内各个适应症的首选药物，占销售逾80%。该行将2026及2027年的每股盈利预测，由3.43及8.81元，下调至1.39及7.32元，以反映去年下半年业绩表现，及近期药物销售预测下调等；维持“买入”评级，目标价由531.69港元降至526.49港元。(港股报价延迟最少十五分钟。沽空资料截至 2026-03-23 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511735/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511735/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2621348710","title":"《大行》瑞銀降科倫博泰(06990.HK)目標價至578元  降盈測重申「買入」","url":"https://stock-news.laohu8.com/highlight/detail?id=2621348710","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621348710?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 10:07","pubTimestamp":1774318020,"startTime":"0","endTime":"0","summary":"瑞银发表研究报告指，科伦博泰-B去年下半年收入11亿元人民币(下同)，按年升101%，符合该行及市场预期；净亏损2.37亿元，好过该行及市场预期。因应该业绩，该行将2026及2027年sac-TMT销售预测下调至14亿元及26亿元，但上调授权收入预测，因今年更多第三期临床数据释出后或有潜在的里程碑付款；2026年每股盈利预测由亏损0.54元下调至亏损1.38元，2027年盈利预测由2.03元下调至0.09元；重申“买入”评级，目标价由593港元下调至578港元。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511728/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511728/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2621721247","title":"ADC一哥，扣動新一輪增長扳機","url":"https://stock-news.laohu8.com/highlight/detail?id=2621721247","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621721247?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 18:22","pubTimestamp":1774261341,"startTime":"0","endTime":"0","summary":"结合其成熟的“端到端”药物开发能力及经过市场验证的商业化路径，公司已悄然扣动新一轮的增长扳机。过去一年多来，芦康沙妥珠单抗获批了4项适应症，一举囊括了肺癌、乳腺癌两大癌种。比如，在备受瞩目的RDC领域，科伦博泰的SKB107在去年7月启动了一项治疗晚期实体瘤骨转移患者的I期临床。在ADC领域完成体系化的跨周期布局之后，科伦博泰正依托底层的创新势能，稳步向综合型、全面型治疗领域延伸。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","BK4231","ADC","06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2621774143","title":"《業績》科倫博泰生物(06990.HK)全年虧損擴至3.82億人幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2621774143","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621774143?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 17:59","pubTimestamp":1774259940,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(06990.HK) 公布截至去年12月底止全年业绩，营业额20.58亿元人民币(下同)，按年升6.5%。亏损扩大至3.82亿元，上年同期蚀2.67亿元；每股亏损1.66元。不派息。过往派息公布日期派息事项派息内容2025/08/18中期业绩无派息2025/03/24末期业绩无派息2024/08/19中期业绩无派息2024/03/25末期业绩无派息撇除以权益结算的股份支付，经调整亏损由对上财年1.18亿元扩至2.11亿元。(hc/da)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-23 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511534/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1511534/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2620884257","title":"科倫博泰生物－Ｂ(06990)股價下跌5.044%，現價港幣$410.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2620884257","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620884257?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 14:54","pubTimestamp":1773989640,"startTime":"0","endTime":"0","summary":"[下跌股]科伦博泰生物－Ｂ(06990) 股价在下午02:54比前收市价下跌5.044%，现股价为港币$410.4。至目前为止，今日最高价为$442.0，而最低价为$410.4。总成交量为46.206万股，总成交金额为港币$1.947亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603203417/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603203417/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2620203185","title":"【券商聚焦】中國銀河：「十五五」首次將生物醫藥列為國家新興支柱產業，持續發力研發創新","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203185","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620203185?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 09:23","pubTimestamp":1773969824,"startTime":"0","endTime":"0","summary":"“十四五”规划重点关注医药创新产品产业化、医药产业化技术攻关、疫苗和短缺药品供应保障、产品质量升级、医药工业绿色低碳等五大工程，成效斐然，中国创新药获批上市数量由2015年的11款提升至2024年的92款，2024年共有22款国产化药和17款国产生物药获批上市，国产创新药占比提升至42%。“十五五”规划提出健全医疗、医保、医药协同发展和治理机制，生物医药产业首次被列为国家“新兴支柱产业”，战略定位进一步提升。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","LU0348766576.USD","BK4588","LU2778985437.USD","LU2045819591.USD","02359","161726","XBI","HK0000306701.USD","LU2328871848.SGD","02696","601881","HK0000320223.HKD","LU2476274308.USD","06881","LU0348825331.USD","BK1141","BK1588","HK0000306685.HKD","02268","09995","LU2476274720.SGD","BK4585","LU0561508036.HKD","LU0708995583.HKD","09926","LU0348767384.USD","LU1720050803.USD","LU0417516571.SGD","LU1770034418.SGD","06160","LU0348735423.USD","399441","LU2125910500.SGD","LU2242644610.SGD","SG9999014674.SGD","LU0052750758.USD","BK1147","BK1161","BK1564","LU0196878994.USD","IE00B543WZ88.USD","LU0540923850.HKD","06990","BK4581","LU0588546209.SGD","02162","LU1969619763.USD","BK0276"],"gpt_icon":0},{"id":"2620225732","title":"科倫博泰生物-B(06990)：核心產品蘆康沙妥珠單抗(sac-TMT)於2025年歐洲肺癌大會上公布的研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225732","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225732?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 22:46","pubTimestamp":1773845187,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，本公司靶向人滋养细胞表面抗原2抗体偶联药物芦康沙妥珠单抗(佳泰莱)关键临床研究的总生存期最终分析结果将在于当地时间3月25日至28日在丹麦哥本哈根举行的2026年欧洲肺癌大会的小型口头报告专场公布。基于这一积极结果，芦康沙妥珠单抗获国家药品监督管理局批准此适应症，该适应症已被纳入国家医保目录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2619431587","title":"科倫博泰生物－Ｂ(06990)股價上升5.066%，現價港幣$414.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2619431587","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619431587?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 13:39","pubTimestamp":1773639540,"startTime":"0","endTime":"0","summary":"[上升股]科伦博泰生物－Ｂ(06990) 股价在下午01:39比前收市价上升5.066%，现股价为港币$414.8。至目前为止，今日最高价为$414.8，而最低价为$388.4。总成交量为25.676万股，总成交金额为港币$1.039亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603164881/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603164881/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2618929907","title":"每日沽空追蹤 | 科倫博泰生物-B 03月11日沽空量成交5.25萬股，沽空比例為14.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929907","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618929907?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 16:30","pubTimestamp":1773217838,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间03月11日，跌1.79%，卖空量成交5.25万股，较上一交易日减少62.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163603a6b796e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163603a6b796e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2618516049","title":"科倫博泰生物-B(06990)與科倫嘉訊訂立2026年輔助性市場管理服務框架協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2618516049","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618516049?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 22:44","pubTimestamp":1773153858,"startTime":"0","endTime":"0","summary":"与科伦嘉讯集团订立2026年辅助性市场管理服务框架协议，将使本公司能够借助科伦嘉讯集团现有的资源对sac-TMT进行推广，从而更有效地达成列名目标。本公司认为，科伦嘉讯集团具备所需的行业知识，能够有效提供2026年辅助性市场管理服务框架协议项下的服务，且委聘科伦嘉讯集团可避免因委聘先前并无与本公司合作的新服务提供商而产生的前期成本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1107973285","title":"港股異動 | 創新藥概念股普漲，康方生物、科倫博泰生物升逾9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107973285","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107973285?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 09:58","pubTimestamp":1773107886,"startTime":"0","endTime":"0","summary":"3月10日，创新药概念股走强，$康方生物(09926)$、$科伦博泰(06990)$生物涨超9%，$三生制药(01530)$、$亚盛医药(AAPG)$、$康诺亚(02162)$涨超5%，$海西新药(02637)$涨近4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3f44e86c3bddb2de2b4a93e8a962fb5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","06990","LU1961090484.USD","IE00B543WZ88.USD","LU2399975544.HKD","LU2778985437.USD","LU2476274308.USD","LU2476274720.SGD","LU2488822045.USD","BK4585","LU0348767384.USD","IE00B5MMRT66.SGD","LU0540923850.HKD","BK4588","LU1720050803.USD","LU0348784397.USD","09926","LU0348766576.USD","IE00BPRC5H50.USD","LU0348825331.USD","BK1574","LU0561508036.HKD","LU0348783233.USD","BK1161","LU0348735423.USD","LU0348827113.USD","LU0417516571.SGD","LU0417516902.SGD","LU0417516738.SGD","LU1794554557.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}